ESC Premium Access

Hot Line: Late-Breaking Clinical Trials 4

Event: ESC CONGRESS 2017
Topic: Miscellaneous
Session type: Hot Line
Date: 29 August 2017
Time: 08:30 - 10:00

Congress Session

13 presentations in this session

Clinical effects of anacetrapib in people with established vascular disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55-REVEAL) trial

Speaker: Professor M. Landray (Oxford, GB)
Thumbnail

Discussant review: Clinical effects of anacetrapib in people with established vascular disease: Results of the Randomized EValuation of the Effects of Anacetrapib through Lipid-modification (HPS3/TIMI55-REVEAL) trial

Speaker: Professor J. Chapman (Paris, FR)
Thumbnail

Panel discussion.

Thumbnail

Does intensive treat-to-target LDL-C lowering therapy using statin in patients of diabetic retinopathy reduce cardiovascular events?: the EMPATHY study

Speaker: Professor H. Itoh (Tokyo, JP)
Thumbnail

Discussant review: Does intensive treat-to-target LDL-C lowering therapy using statin in patients of diabetic retinopathy reduce cardiovascular events?: the EMPATHY study

Speaker: Professor E. Prescott (Copenhagen, DK)
Thumbnail

Panel discussion.

Thumbnail

Withdrawn - Exercise training in diastolic heart failure (Ex-DHF): a multicenter, prospective, randomized, controlled, parallel group trial

Thumbnail

Catheter Ablation compared with optimized Pharmacological Therapy for Atrial Fibrillation, a randomized multicentre study of quality of life and implantable cardiac monitoring after 12 month follow-up

Speaker: Professor C. Blomstrom-Lundqvist (Orebro, SE)
Thumbnail

Discussant review: Catheter Ablation compared with optimized Pharmacological Therapy for Atrial Fibrillation, a randomized multicentre study of quality of life and implantable cardiac monitoring after 12 month follow-up

Speaker: Professor N. Marrouche (New Orleans, US)
Thumbnail

Panel discussion.

Thumbnail

8 speakers from this session

Professor Martin Landray

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
6 presentations
0 follower

Professor John Chapman

Sorbonne University, Paris (France)
15 presentations
0 follower

Professor Hiroshi Itoh

Keio University School of Medicine, Tokyo (Japan)
2 presentations
0 follower

Professor Eva Prescott

Bispebjerg University Hospital, Copenhagen (Denmark)
15 presentations
0 follower

Professor Carina Blomstrom-Lundqvist

Orebro University Hospital, Orebro (Sweden)
27 presentations
2 followers

Professor Nassir Marrouche

Tulane University, New Orleans (United States of America)
22 presentations
0 follower

Professor Julian Halcox

Swansea University, Swansea (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

Professor Christophe Leclercq

University Hospital of Rennes - Hospital Pontchaillou, Rennes (France)
46 presentations
3 followers

This platform is supported by

logo Novo Nordisk